Incidence and impact of scheduled endoscopic surveillance on recurrence after curative endoscopic resection for early gastric cancer

Kyu Yeon Hahn, Jun Chul Park, Eun Hye Kim, Suji Shin, Chan Hyuk Park, Hyunsoo Chung, Sung Kwan Shin, SangKil Lee, Yongchan Lee

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background and Aims The aim of this study was to identify the incidence of recurrent lesions after endoscopic submucosal dissection (ESD) and to determine whether scheduled endoscopic surveillance might control their development and treatment. Methods We reviewed the clinical data of patients who underwent gastric ESD between March 2007 and April 2014. Results A total of 1347 patients who underwent curative ESD for early gastric cancer that met the expanded indication for ESD were analyzed. Of these, recurrence at the previous ESD site occurred in 39 patients, whereas recurrence in the stomach at a site other than the ESD site occurred in 102 patients. Older age, intestinal metaplasia, flat or depressed lesions, and ESD criteria were associated with recurrence in the stomach in places other than the ESD site. The annual incidence was.84% for recurrence at the previous ESD site and 2.48% for recurrence in the stomach at other than the ESD site. In cases of local recurrence and metachronous lesions, there was a significant difference between the short- and long-surveillance interval group (≤12 months vs >12 months) in the proportions of recurrent adenocarcinoma (31.9% vs 60.9%, P =.021), additional gastrectomy (7.1% vs 46.2%, P =.033), and size (8.92 ± 4.17 mm vs 18.08 ± 10.47 mm, P =.010). Conclusions Scheduled endoscopy surveillance is necessary for detecting recurrent lesions. In addition, scheduled endoscopy surveillance might help to detect recurrent lesions at a stage early enough for a curative resection.

Original languageEnglish
Pages (from-to)628-638.e1
JournalGastrointestinal Endoscopy
Volume84
Issue number4
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Stomach Neoplasms
Recurrence
Incidence
Stomach
Endoscopy
Endoscopic Mucosal Resection
Metaplasia
Gastrectomy
Adenocarcinoma

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Cite this

Hahn, Kyu Yeon ; Park, Jun Chul ; Kim, Eun Hye ; Shin, Suji ; Park, Chan Hyuk ; Chung, Hyunsoo ; Shin, Sung Kwan ; Lee, SangKil ; Lee, Yongchan. / Incidence and impact of scheduled endoscopic surveillance on recurrence after curative endoscopic resection for early gastric cancer. In: Gastrointestinal Endoscopy. 2016 ; Vol. 84, No. 4. pp. 628-638.e1.
@article{b57bf859bd0844fc91573f2efcc6f94d,
title = "Incidence and impact of scheduled endoscopic surveillance on recurrence after curative endoscopic resection for early gastric cancer",
abstract = "Background and Aims The aim of this study was to identify the incidence of recurrent lesions after endoscopic submucosal dissection (ESD) and to determine whether scheduled endoscopic surveillance might control their development and treatment. Methods We reviewed the clinical data of patients who underwent gastric ESD between March 2007 and April 2014. Results A total of 1347 patients who underwent curative ESD for early gastric cancer that met the expanded indication for ESD were analyzed. Of these, recurrence at the previous ESD site occurred in 39 patients, whereas recurrence in the stomach at a site other than the ESD site occurred in 102 patients. Older age, intestinal metaplasia, flat or depressed lesions, and ESD criteria were associated with recurrence in the stomach in places other than the ESD site. The annual incidence was.84{\%} for recurrence at the previous ESD site and 2.48{\%} for recurrence in the stomach at other than the ESD site. In cases of local recurrence and metachronous lesions, there was a significant difference between the short- and long-surveillance interval group (≤12 months vs >12 months) in the proportions of recurrent adenocarcinoma (31.9{\%} vs 60.9{\%}, P =.021), additional gastrectomy (7.1{\%} vs 46.2{\%}, P =.033), and size (8.92 ± 4.17 mm vs 18.08 ± 10.47 mm, P =.010). Conclusions Scheduled endoscopy surveillance is necessary for detecting recurrent lesions. In addition, scheduled endoscopy surveillance might help to detect recurrent lesions at a stage early enough for a curative resection.",
author = "Hahn, {Kyu Yeon} and Park, {Jun Chul} and Kim, {Eun Hye} and Suji Shin and Park, {Chan Hyuk} and Hyunsoo Chung and Shin, {Sung Kwan} and SangKil Lee and Yongchan Lee",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.gie.2016.03.1404",
language = "English",
volume = "84",
pages = "628--638.e1",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "4",

}

Incidence and impact of scheduled endoscopic surveillance on recurrence after curative endoscopic resection for early gastric cancer. / Hahn, Kyu Yeon; Park, Jun Chul; Kim, Eun Hye; Shin, Suji; Park, Chan Hyuk; Chung, Hyunsoo; Shin, Sung Kwan; Lee, SangKil; Lee, Yongchan.

In: Gastrointestinal Endoscopy, Vol. 84, No. 4, 01.01.2016, p. 628-638.e1.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Incidence and impact of scheduled endoscopic surveillance on recurrence after curative endoscopic resection for early gastric cancer

AU - Hahn, Kyu Yeon

AU - Park, Jun Chul

AU - Kim, Eun Hye

AU - Shin, Suji

AU - Park, Chan Hyuk

AU - Chung, Hyunsoo

AU - Shin, Sung Kwan

AU - Lee, SangKil

AU - Lee, Yongchan

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background and Aims The aim of this study was to identify the incidence of recurrent lesions after endoscopic submucosal dissection (ESD) and to determine whether scheduled endoscopic surveillance might control their development and treatment. Methods We reviewed the clinical data of patients who underwent gastric ESD between March 2007 and April 2014. Results A total of 1347 patients who underwent curative ESD for early gastric cancer that met the expanded indication for ESD were analyzed. Of these, recurrence at the previous ESD site occurred in 39 patients, whereas recurrence in the stomach at a site other than the ESD site occurred in 102 patients. Older age, intestinal metaplasia, flat or depressed lesions, and ESD criteria were associated with recurrence in the stomach in places other than the ESD site. The annual incidence was.84% for recurrence at the previous ESD site and 2.48% for recurrence in the stomach at other than the ESD site. In cases of local recurrence and metachronous lesions, there was a significant difference between the short- and long-surveillance interval group (≤12 months vs >12 months) in the proportions of recurrent adenocarcinoma (31.9% vs 60.9%, P =.021), additional gastrectomy (7.1% vs 46.2%, P =.033), and size (8.92 ± 4.17 mm vs 18.08 ± 10.47 mm, P =.010). Conclusions Scheduled endoscopy surveillance is necessary for detecting recurrent lesions. In addition, scheduled endoscopy surveillance might help to detect recurrent lesions at a stage early enough for a curative resection.

AB - Background and Aims The aim of this study was to identify the incidence of recurrent lesions after endoscopic submucosal dissection (ESD) and to determine whether scheduled endoscopic surveillance might control their development and treatment. Methods We reviewed the clinical data of patients who underwent gastric ESD between March 2007 and April 2014. Results A total of 1347 patients who underwent curative ESD for early gastric cancer that met the expanded indication for ESD were analyzed. Of these, recurrence at the previous ESD site occurred in 39 patients, whereas recurrence in the stomach at a site other than the ESD site occurred in 102 patients. Older age, intestinal metaplasia, flat or depressed lesions, and ESD criteria were associated with recurrence in the stomach in places other than the ESD site. The annual incidence was.84% for recurrence at the previous ESD site and 2.48% for recurrence in the stomach at other than the ESD site. In cases of local recurrence and metachronous lesions, there was a significant difference between the short- and long-surveillance interval group (≤12 months vs >12 months) in the proportions of recurrent adenocarcinoma (31.9% vs 60.9%, P =.021), additional gastrectomy (7.1% vs 46.2%, P =.033), and size (8.92 ± 4.17 mm vs 18.08 ± 10.47 mm, P =.010). Conclusions Scheduled endoscopy surveillance is necessary for detecting recurrent lesions. In addition, scheduled endoscopy surveillance might help to detect recurrent lesions at a stage early enough for a curative resection.

UR - http://www.scopus.com/inward/record.url?scp=84964861525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964861525&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2016.03.1404

DO - 10.1016/j.gie.2016.03.1404

M3 - Article

VL - 84

SP - 628-638.e1

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 4

ER -